Role of Neurochemicals in Schizophrenia
Authors:
Open Access
- 30 August 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Psychopharmacology
- Vol. 9 (2) , 144-161
Abstract
Background: Schizophrenia is a complex, unpredictable and severe psychiatric disorder, which affects several domains of cognition, behavior and characterized by positive, negative, and cognitive symptoms. Etiology of schizophrenia represents the involvement of environmental factors, role of genes, social stressors, like discrimination or economic hardship, relationships, childhood difficulty, use of cannabis in adolescence, maternal stress, nutritional deficiencies, maternal infections, intrauterine growth retardation, and complications of pregnancy, while pathophysiology represents dysfunctional neurotransmission of dopamine, stress-associated signaling cascades (gabanergic, glutamatergic, cholinergic, serotonin, and adrenergic singling cascades) and enzymatic changes (acetylcholinesterase, catechol-o-methyl-transferase, monoamine oxidase, and phosphodiesterase).Objective: The objective of the current review is to determine the role of pathophysiological hypothesis impairments leading to positive, negative and cognitive symptoms of schizophrenia.Methods: Various pathophysiological hypotheses of schizophrenia were identified through searching relevant databases including PubMed, Scopus, and Web of Science up to the year 2019, using the keywords schizophrenia, role of dopamine, acetylcholine, oxidative stress, and inflammation in schizophrenia.Result: Alterations in the neurotransmission of dopamine, stress-associated signaling cascades (Gabanergic, glutamatergic, cholinergic, serotonin, and adrenergic singling cascades) and enzymatic changes (acetylcholinesterase, catechol-o-methyl-transferase, monoamine oxidase, and phosphodiesterase) were compiled in this review for easy learning of Schizophrenia.Conclusion: Schizophrenia is a major illness defined by delusions, hallucinations, disorganized behavior, and cognitive difficulties such as memory loss. This review aims to provide a brief overview of neurotransmitter role as well as other pathophysiological alterations in schizophrenia. A focus on more predictive animal models and specific biomarkers for positive, negative and cognitive symptoms will help to identify and develop novel therapeutic agents with fewer side effects.Keywords
This publication has 134 references indexed in Scilit:
- The Neurobiology of Thought: The Groundbreaking Discoveries of Patricia Goldman-Rakic 1937-2003Cerebral Cortex, 2013
- COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: An exploratory studyNeuroscience Letters, 2013
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophreniaTrends in Pharmacological Sciences, 2011
- Language in Schizophrenia Part 1: An IntroductionLanguage and Linguistics Compass, 2010
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009
- Targeted disruption of serine racemase affects glutamatergic neurotransmission and behaviorMolecular Psychiatry, 2008
- The biochemical womb of schizophrenia: A reviewIndian Journal of Clinical Biochemistry, 2008
- Is COMT a Susceptibility Gene for Schizophrenia?Schizophrenia Bulletin, 2007
- Psychomotor Slowing in SchizophreniaSchizophrenia Bulletin, 2007
- Historical Development of the Dopamine Hypothesis of SchizophreniaJournal of the History of the Neurosciences, 2002